Navigation Links
Invida Selects LaVoie Group as Public Relations Agency of Record
Date:2/8/2010

LaVoie Group, a life science-focused strategic communications agency, announced today that it has been selected by Invida Group, the leading provider of healthcare brands and services in Asia Pacific, to develop and execute its corporate communications and public relations program.

Salem, MA (Vocus) February 8, 2010 -- LaVoie Group, a life science-focused strategic communications agency, announced today that it has been selected by Invida Group, the leading provider of healthcare brands and services in Asia Pacific, to develop and execute its corporate communications and public relations program. Singapore-based Invida has a presence in 13 countries in the Asia-Pacific region, and has selected LaVoie Group to build upon its corporate identity and brand awareness as the company moves into a phase of focused expansion in key growth regions such as China and India.

Donna L. LaVoie, President & CEO of LaVoie Group, commented, "Invida provides pharmaceutical and biotechnology partners proven brand and sales experience and track record in bringing their products to the three billion patients in the fastest growing region in the world – the Asia-Pacific region. We look forward to continuing our work with the Invida team to develop and execute a corporate communications program, designed to align with Invida’s business strategy and growth opportunities in these exciting markets.”

John A. Graham, Chief Executive Officer of Invida Group Pte Ltd, added, "We selected LaVoie Group for their experience working with leading life sciences corporate brands. As Invida expands throughout Asia Pacific and grows its presence in these key markets, LaVoie Group will help us in creating and executing a strong and cohesive strategy to further our message as we seek to continue working with top multi-national corporations to market and sell their product lines throughout the region.”

About Invida Group Pte Ltd.
Invida improves the lives of patients in Asia by commercializing differentiated pharmaceutical products of superior quality - the result of which will allow all our stakeholders to prosper. We do this through our proven brand marketing and sales know-how, strong expertise across a number of key therapeutic categories and deep experience in all critical Asian markets. Comprehensive functional capabilities provide rapid market access delivered by our passionate team of professionals.

With more than 4,000 employees in 13 countries in Asia Pacific, Invida operates across the commercial value chain from regulatory approval and product launch to lifecycle management. We manage a portfolio of proprietary healthcare brands, as well as licensed products from small biotech firms and large multinational companies. Partnering is a critical component of Invida’s business model. We collaborate closely with our partners in developing effective strategies and put our extensive experience behind maximizing the potential of the assets entrusted to us. For more information, please visit http://www.invida.com.

About LaVoie Group, Inc.
LaVoie Group provides senior-level counsel and tactical implementation of strategic communications programs designed to properly position, create visibility and drive value for each client. We help our life sciences companies attract capital, reach corporate partners, generate revenue and build their companies through integrated communications programs. In addition to Invida, our clients include emerging and leading global brands in the life science sector, such as Pfizer, sanofi-aventis, Vertex Pharmaceuticals, Genetix Pharmaceuticals, Rockwell Medical, Cardioxyl Pharmaceuticals, and Profectus Biosciences.

In 2009, LaVoie Group was selected for three industry awards including the coveted Impact Award for "Best Industry-Exclusive Agency," sponsored by the League of American Communications Professionals (LACP) and the Bell Ringer merit award for corporate identity by the New England Publicity Club. LaVoie Group is also ranked by O’Dwyer’s PR Report as one of the leading independent healthcare PR firms in the U.S. For more information, please visit http://www.lavoiegroup.com.

Contact:
Donna L. LaVoie
President & CEO
LaVoie Group
978-745-4200 X103
http://www.lavoiegroup.com

# # #

Read the full story at http://www.prweb.com/releases/Invida_Group/LaVoie_Group/prweb3573384.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Biotech Company Ansaris Selects Surety for Integrity and Authenticity Protection of Its Lab Informatics Data
2. Japan Science and Technology Agency (JST) Selects Scopus Custom Data for Citation Linkage Analysis Between Scientific Articles and Patents
3. Molecular Genetics Core Facility at Childrens Hospital Boston Selects HybSelect from febit for Targeted Resequencing
4. Quintiles Selects invivodata as Primary Partner for ePRO Solutions; Collaboration to Enhance Value, Effectiveness and Speed in Drug Development
5. Leading Global CRO Selects iCardiac as Preferred Vendor
6. The Massachusetts Biotechnology Council Selects Social Media Marketing Agency 451 Marketing To Develop A Social Media Strategy For 2010
7. Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property
8. WuXi PharmaTech Selects Labcyte POD(TM) 810 Platform for High-Throughput Screening
9. Another Top Five Pharmaceutical Company Selects iCardiac as Preferred Provider of ECG Core Lab Services
10. iSirona Selects New Chairman of the Board
11. Memorial Sloan-Kettering Selects Artemis as Affiliate for India
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Invida Selects LaVoie Group as Public Relations Agency of Record
(Date:8/15/2017)... Calif. , Aug. 15, 2017 After spending the ... and support with crowdsourced data collection, GeneFo now offers this platform ... in aligning and amplifying support, adherence, and data collection vis a ... medical foundations mark the successful launch of this offer. ... GeneFo ...
(Date:8/15/2017)... ... August 15, 2017 , ... Pittcon is ... for analytical and scientific instruments. This year’s symposium, organized by the Pittcon 2018 ... Spectrometry for Bioanalytical Applications.” This dynamic presentation will discuss novel ionization processes, high ...
(Date:8/15/2017)... ... August 15, 2017 , ... The Conference Forum and ... programming through a series of upcoming panels and events. The partnership culminates with the ... Roosevelt Hotel in New York City. , “With our experience in producing the Immuno-Oncology ...
(Date:8/14/2017)... (PRWEB) , ... August 14, 2017 , ... ... characterized and performing antibodies. Key researchers in the antibody community have recently come ... and consistency for antibodies in the laboratory. , The team at ...
Breaking Biology Technology:
(Date:5/16/2017)... DALLAS , May 16, 2017   ... for health organizations, and MD EMR Systems ... certified development partner for GE, have established a ... Patient Portal product and the GE Centricity™ products, ... Centricity EMR. These new integrations ...
(Date:4/19/2017)... ALBANY, New York , April 19, 2017 /PRNewswire/ ... highly competitive, as its vendor landscape is marked by ... in the market is however held by five major ... and Safran. Together these companies accounted for nearly 61% ... majority of the leading companies in the global military ...
(Date:4/13/2017)... 2017 UBM,s Advanced Design and Manufacturing event ... emerging and evolving technology through its 3D Printing and ... alongside the expo portion of the event and feature ... focused on trending topics within 3D printing and smart ... event will take place June 13-15, 2017 at the Jacob ...
Breaking Biology News(10 mins):